From COVID and Beyond

Lab Analytics to Serve Global Bio-Surveillance and the Molecular Benefits of PCR in Platforms Testing COVID/Flu

Wednesday, July 27
7 – 8:30 a.m.
Hyatt Regency, Regency Ballroom C
Sponsored by Thermo Fisher Scientific


Discover how real-time analytics of your laboratory assays can provide valuable insights through key metrics, such as test outcomes, assay performance, and laboratory proficiency monitoring, including cross-assay comparison. As laboratories move beyond COVID testing, there are many advantages to using multiplex PCR tests in the management of respiratory tract infections.


After attending this session, participants will be able to:

  • Examine various scenarios of diagnostics latency and care gaps, including the potential impact effect on patient outcomes.
  • Discuss analytical and practical performance differences between different platforms.
  • Describe the benefits of multiplex PCR testing.


Manoj Gandhi
Sr. Director, Medical Affairs Clinical
Thermo Fisher Scientific
Carlsbad, CA


Imran Mujawar, MBBS, MS
Sr. Staff Data Scientist
Thermo Fisher Scientific
South San Francisco, CA

Anami Patel, PhD
Popular Healthcare
Memphis, TN